Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension

被引:87
作者
Gamba, G
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mol Physiol Unit, Mexico City 14000, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico
关键词
distal tubule; sodium chloride; diuretics; claudins; paracellular;
D O I
10.1152/ajprenal.00311.2004
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
A recently discovered family of protein kinases is responsible for an autosomal-dominant disease known as Gordon's syndrome or pseudohypoaldosteronism type II (PHA-II) that features hyperkalemia and hyperchloremic metabolic acidosis, accompanied by hypertension and hypercalciuria. Four genes have been described in this kinase family, which has been named WNK, due to the absence of a key lysine in kinase subdomain II ( with no K kinases). Two of these genes, WNK1 and WNK4 located in human chromosomes 12 and 17, respectively, are responsible for PHA-II. Immunohystochemical analysis revealed that WNK1 and WNK4 are predominantly expressed in the distal convoluted tubule and collecting duct. The physiological studies have shown that WNK4 downregulates the activity of ion transport pathways expressed in these nephron segments, such as the apical thiazide-sensitive Na(+)-Cl(-) cotransporter and apical secretory K(+) channel ROMK, as well as upregulates paracellular chloride transport and phosphorylation of tight junction proteins such as claudins. In addition, WNK4 downregulates other Cl(-) influx pathways such as the basolateral Na(+)-K(+)-2Cl(-) cotransporter and Cl(-)/HCO(3)(-) exchanger. WNK4 mutations behave as a loss of function for the Na(+)-Cl(-) cotransporter and a gain of function when it comes to ROMK and claudins. These dual effects of WNK4 mutations fit with proposed mechanisms for developing electrolyte abnormalities and hypertension in PHA-II and point to WNK4 as a multifunctional regulator of diverse ion transporters.
引用
收藏
页码:F245 / F252
页数:8
相关论文
共 54 条
[21]   WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding [J].
Lee, BH ;
Min, XS ;
Heise, CJ ;
Xu, BE ;
Chen, S ;
Shu, HJ ;
Luby-Phelps, K ;
Goldsmith, EJ ;
Cobb, MH .
MOLECULAR CELL, 2004, 15 (05) :741-751
[22]   BLOCKADE OF DISTAL NEPHRON SODIUM-TRANSPORT ATTENUATES PRESSURE NATRIURESIS IN DOGS [J].
MAJID, DSA ;
NAVAR, LG .
HYPERTENSION, 1994, 23 (06) :1040-1045
[23]   Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21 [J].
Mansfield, TA ;
Simon, DB ;
Farfel, Z ;
Bia, M ;
Tucci, JR ;
Lebel, M ;
Gutkin, M ;
Vialettes, B ;
Christofilis, MA ;
KauppinenMakelin, R ;
Mayan, H ;
Risch, N ;
Lifton, RP .
NATURE GENETICS, 1997, 16 (02) :202-205
[24]   THE SPITZER-WEINSTEIN SYNDROME - ONE FORM OF TYPE-IV RENAL TUBULAR-ACIDOSIS AND ITS RESPONSE TO HYDROCHLOROTHIAZIDE [J].
MARGOLIS, BL ;
LIFSCHITZ, MD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 7 (03) :241-244
[25]   Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: Description of a large family with the Q565E WNK4 mutation [J].
Mayan, H ;
Munter, G ;
Shaharabany, M ;
Mouallem, M ;
Pauzner, R ;
Holtzman, EJ ;
Farfel, Z .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :4025-4030
[26]   Pseudohypoaldosteronism type II: Marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density [J].
Mayan, H ;
Vered, I ;
Mouallem, M ;
Tzadok-Witkon, M ;
Pauzner, R ;
Farfel, Z .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07) :3248-3254
[27]   Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension [J].
Min, XS ;
Lee, BH ;
Cobb, MH ;
Goldsmith, EJ .
STRUCTURE, 2004, 12 (07) :1303-1311
[28]   Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome [J].
Moudgil, A ;
Rodich, G ;
Jordan, SC ;
Kamil, ES .
PEDIATRIC NEPHROLOGY, 2000, 15 (1-2) :60-62
[29]   HUMAN HYPERTENSION CAUSED BY MUTATIONS IN THE KIDNEY ISOZYME OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
MUNE, T ;
ROGERSON, FM ;
NIKKILA, H ;
AGARWAL, AK ;
WHITE, PC .
NATURE GENETICS, 1995, 10 (04) :394-399
[30]   WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain [J].
O'Reilly, M ;
Marshall, E ;
Speirs, HJL ;
Brown, RW .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (10) :2447-2456